title: Robust predictive markers are needed for early detection of trastuzumab-related cardiac dysfunction in breast cancer.
authors.affiliation: MKA Breast Cancer Clinic, Tepe Prime, 06800, Cankaya, Ankara, Turkey. altundag66@yahoo.com.
authors.forename: Kadri
authors.identifier: http://orcid.org/0000-0003-3357-0096
authors.initials: K
authors.lastname: Altundag
mesh_terms: D015415:Biomarkers / Q000097:blood*; D001943:Breast Neoplasms / Q000188:drug therapy*; D066126:Cardiotoxicity / Q000097:blood / Q000209:etiology*; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D000068878:Trastuzumab / Q000009:adverse effects*; D019210:Troponin I / Q000097:blood; D020107:Troponin T / Q000097:blood
chemical_list: D015415:Biomarkers; D010446:Peptide Fragments; D019210:Troponin I; D020107:Troponin T; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain; D007073:Immunoglobulin E; D000068878:Trastuzumab